Medibio announces CE Marking

Latest News

Medibio (ASX:MEB), a mental health technology company, has announced it has received CE (Conformité Européenne) Marking certification for its first release technology product and platform.

CE Marking was granted on 2 May and demonstrates the product complies with European health and safety standards.

The product enables clinicians and individuals to evaluate stress-level phenotypes, combined with dimensional circadian heart-sleep biometrics and physiological biometrics. It works with the company's app-based and web-based platforms to allow for the non-invasive evaluation and monitoring of mental health.

“Acquiring CE Marking represents the successful completion of a lengthy and thorough evaluation process, and marks an important threshold for the company. We are pleased to have delivered against this key milestone. Alongside the recent announcement of our corporate mental health product, this accomplishment provides further validation of the product offering and technology,” said CEO and managing director Jack Cosentino. “We are eager to progress to a new phase, and committed across the organization to deliver exceptional product quality and operational excellence as we work towards transforming mental health care delivery.”